Product Code: GVR-4-68041-034-8
Bioprocess Technology Market Summary
The global bioprocess technology market size was valued at USD 25.8 billion in 2025 and is projected to grow from USD 29.6 billion in 2026 to USD 83.5 billion by 2033, at a CAGR of 15.9% from 2026 to 2033. North America dominated the market, accounting for the largest revenue share of 47.3% in 2025. Market growth is driven by the rising adoption of precision fermentation, along with advancements in bioreactor automation, process monitoring, and scalable fermentation technologies.
Global Bioprocess Technology Market Report Segmentation
This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global bioprocess technology market report based on technology, application, end use, and region:
- Technology Outlook (Revenue, USD Billion, 2021 - 2033)
- Upstream Bioprocessing
- Downstream Bioprocessing
- Others
- Application Outlook (Revenue, USD Billion, 2021 - 2033)
- Monoclonal Antibodies
- Vaccines
- Recombinant Proteins
- Cell & Gene Therapies
- Enzymes
- Other Biologics
- End Use Outlook (Revenue, USD Billion, 2021 - 2033)
- Biopharmaceutical & Pharmaceutical Companies
- CROs & CMOs
- Academic & Research Institutes
- Other End Users
- Regional Outlook (Revenue, USD Billion, 2021 - 2033)
- North America
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
- Asia Pacific
- Japan
- China
- India
- Australia
- Thailand
- South Korea
- Latin America
- Middle East and Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
- Kuwait
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation and Scope
- 1.1.1. Segment Definitions
- 1.1.1.1. Technology Segment
- 1.1.1.2. Application Segment
- 1.1.1.3. End Use Segment
- 1.2. Regional Scope
- 1.3. Estimates and Forecast Timeline
- 1.4. Objectives
- 1.5. Research Methodology
- 1.6. Information Procurement
- 1.6.1. Purchased Database
- 1.6.2. GVR's Internal Database
- 1.6.3. Secondary Sources
- 1.6.4. Primary Research
- 1.7. Information or Data Analysis:
- 1.7.1. Data Analysis Models
- 1.8. Market Formulation & Validation
- 1.9. Model Details
- 1.9.1. Commodity Flow Analysis
- 1.9.2. List of Secondary Sources
- 1.9.3. List of Abbreviations
Chapter 2. Executive Summary
- 2.1. Market Snapshot
- 2.2. Segment Snapshot
- 2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related/Ancillary Market Outlook
- 3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.1.1. Increasing Adoption of Single-Use Technologies
- 3.2.1.2. Rising Adoption of Precision Fermentation
- 3.2.1.3. Growing Focus on Process Automation
- 3.2.2. Market Restraint Analysis
- 3.2.2.1. Complex Process Validation Requirements
- 3.2.2.2. High Initial Investment Costs
- 3.2.3. Market Opportunities Analysis
- 3.2.4. Market Challenges Analysis
- 3.3. Industry Analysis Tools
- 3.3.1. Porter's Five Forces Analysis
- 3.3.1.1. Supplier power
- 3.3.1.2. Buyer power
- 3.3.1.3. Substitution threat
- 3.3.1.4. Threat of new entrant
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTLE Analysis
- 3.3.2.1. Political landscape
- 3.3.2.2. Technological landscape
- 3.3.2.3. Social landscape
- 3.3.2.4. Economic landscape
- 3.3.2.5. Legal landscape
Chapter 4. Technology Business Analysis
- 4.1. Segment Dashboard
- 4.2. Bioprocess Technology Market: Technology Movement Analysis
- 4.3. Upstream Bioprocessing
- 4.3.1. Upstream Bioprocessing Market, 2021 - 2033 (USD Billion)
- 4.4. Downstream Bioprocessing
- 4.4.1. Downstream Bioprocessing Market, 2021 - 2033 (USD Billion)
- 4.5. Others
- 4.5.1. Others Market, 2021 - 2033 (USD Billion)
Chapter 5. Application Business Analysis
- 5.1. Segment Dashboard
- 5.2. Bioprocess Technology Market: Application Movement Analysis
- 5.3. Monoclonal Antibodies
- 5.3.1. Monoclonal Antibodies Market, 2021 - 2033 (USD Billion)
- 5.4. Vaccines
- 5.4.1. Vaccines Market, 2021 - 2033 (USD Billion)
- 5.5. Recombinant Proteins
- 5.5.1. Recombinant Proteins Market, 2021 - 2033 (USD Billion)
- 5.6. Cell & Gene Therapies
- 5.6.1. Cell & Gene Therapies Market, 2021 - 2033 (USD Billion)
- 5.7. Enzymes
- 5.7.1. Enzymes Market, 2021 - 2033 (USD Billion)
- 5.8. Other Biologics
- 5.8.1. Other Biologics Market, 2021 - 2033 (USD Billion)
Chapter 6. End Use Business Analysis
- 6.1. Segment Dashboard
- 6.2. Bioprocess Technology Market: End Use Movement Analysis
- 6.3. Biopharmaceutical & Pharmaceutical Companies
- 6.3.1. Biopharmaceutical & Pharmaceutical Companies Market, 2021 - 2033 (USD Billion)
- 6.4. CROs & CMOs
- 6.4.1. CROs & CMOs Market, 2021 - 2033 (USD Billion)
- 6.5. Academic & Research Institutes
- 6.5.1. Academic & Research Institutes Market, 2021 - 2033 (USD Billion)
- 6.6. Other End Users
- 6.6.1. Other End Users Market, 2021 - 2033 (USD Billion)
Chapter 7. Regional Business Analysis
- 7.1. Bioprocess Technology Market Share By Region, 2025 & 2033
- 7.2. North America
- 7.2.1. North America Bioprocess Technology Market, 2021 - 2033 (USD Billion)
- 7.2.2. U.S.
- 7.2.2.1. Key Country Dynamics
- 7.2.2.2. Competitive Scenario
- 7.2.2.3. Regulatory Framework
- 7.2.2.4. U.S. Bioprocess Technology Market, 2021 - 2033 (USD Billion)
- 7.2.3. Canada
- 7.2.3.1. Key Country Dynamics
- 7.2.3.2. Competitive Scenario
- 7.2.3.3. Regulatory Framework
- 7.2.3.4. Canada Bioprocess Technology Market, 2021 - 2033 (USD Billion)
- 7.2.4. Mexico
- 7.2.4.1. Key Country Dynamics
- 7.2.4.2. Competitive Scenario
- 7.2.4.3. Regulatory Framework
- 7.2.4.4. Mexico Bioprocess Technology Market, 2021 - 2033 (USD Billion)
- 7.3. Europe
- 7.3.1. Europe Bioprocess Technology Market, 2021 - 2033 (USD Billion)
- 7.3.2. UK
- 7.3.2.1. Key Country Dynamics
- 7.3.2.2. Competitive Scenario
- 7.3.2.3. Regulatory Framework
- 7.3.2.4. UK Bioprocess Technology Market, 2021 - 2033 (USD Billion)
- 7.3.3. Germany
- 7.3.3.1. Key Country Dynamics
- 7.3.3.2. Competitive Scenario
- 7.3.3.3. Regulatory Framework
- 7.3.3.4. Germany Bioprocess Technology Market, 2021 - 2033 (USD Billion)
- 7.3.4. France
- 7.3.4.1. Key Country Dynamics
- 7.3.4.2. Competitive Scenario
- 7.3.4.3. Regulatory Framework
- 7.3.4.4. France Bioprocess Technology Market, 2021 - 2033 (USD Billion)
- 7.3.5. Italy
- 7.3.5.1. Key Country Dynamics
- 7.3.5.2. Competitive Scenario
- 7.3.5.3. Regulatory Framework
- 7.3.5.4. Italy Bioprocess Technology Market, 2021 - 2033 (USD Billion)
- 7.3.6. Spain
- 7.3.6.1. Key Country Dynamics
- 7.3.6.2. Competitive Scenario
- 7.3.6.3. Regulatory Framework
- 7.3.6.4. Spain Bioprocess Technology Market, 2021 - 2033 (USD Billion)
- 7.3.7. Denmark
- 7.3.7.1. Key Country Dynamics
- 7.3.7.2. Competitive Scenario
- 7.3.7.3. Regulatory Framework
- 7.3.7.4. Denmark Bioprocess Technology Market, 2021 - 2033 (USD Billion)
- 7.3.8. Sweden
- 7.3.8.1. Key Country Dynamics
- 7.3.8.2. Competitive Scenario
- 7.3.8.3. Regulatory Framework
- 7.3.8.4. Sweden Bioprocess Technology Market, 2021 - 2033 (USD Billion)
- 7.3.9. Norway
- 7.3.9.1. Key Country Dynamics
- 7.3.9.2. Competitive Scenario
- 7.3.9.3. Regulatory Framework
- 7.3.9.4. Norway Bioprocess Technology Market, 2021 - 2033 (USD Billion)
- 7.4. Asia Pacific
- 7.4.1. Asia Pacific Bioprocess Technology Market, 2021 - 2033 (USD Billion)
- 7.4.2. Japan
- 7.4.2.1. Key Country Dynamics
- 7.4.2.2. Competitive Scenario
- 7.4.2.3. Regulatory Framework
- 7.4.2.4. Japan Bioprocess Technology Market, 2021 - 2033 (USD Billion)
- 7.4.3. China
- 7.4.3.1. Key Country Dynamics
- 7.4.3.2. Competitive Scenario
- 7.4.3.3. Regulatory Framework
- 7.4.3.4. China Bioprocess Technology Market, 2021 - 2033 (USD Billion)
- 7.4.4. India
- 7.4.4.1. Key Country Dynamics
- 7.4.4.2. Competitive Scenario
- 7.4.4.3. Regulatory Framework
- 7.4.4.4. India Bioprocess Technology Market, 2021 - 2033 (USD Billion)
- 7.4.5. Australia
- 7.4.5.1. Key Country Dynamics
- 7.4.5.2. Competitive Scenario
- 7.4.5.3. Regulatory Framework
- 7.4.5.4. Australia Bioprocess Technology Market, 2021 - 2033 (USD Billion)
- 7.4.6. Thailand
- 7.4.6.1. Key Country Dynamics
- 7.4.6.2. Competitive Scenario
- 7.4.6.3. Regulatory Framework
- 7.4.6.4. Thailand Bioprocess Technology Market, 2021 - 2033 (USD Billion)
- 7.4.7. South Korea
- 7.4.7.1. Key Country Dynamics
- 7.4.7.2. Competitive Scenario
- 7.4.7.3. Regulatory Framework
- 7.4.7.4. South Korea Bioprocess Technology Market, 2021 - 2033 (USD Billion)
- 7.5. Latin America
- 7.5.1. Latin America Bioprocess Technology Market, 2021 - 2033 (USD Billion)
- 7.5.2. Brazil
- 7.5.2.1. Key Country Dynamics
- 7.5.2.2. Competitive Scenario
- 7.5.2.3. Regulatory Framework
- 7.5.2.4. Brazil Bioprocess Technology Market, 2021 - 2033 (USD Billion)
- 7.5.3. Argentina
- 7.5.3.1. Key Country Dynamics
- 7.5.3.2. Competitive Scenario
- 7.5.3.3. Regulatory Framework
- 7.5.3.4. Argentina Bioprocess Technology Market, 2021 - 2033 (USD Billion)
- 7.6. MEA
- 7.6.1. MEA Bioprocess Technology Market, 2021 - 2033 (USD Billion)
- 7.6.2. South Africa
- 7.6.2.1. Key Country Dynamics
- 7.6.2.2. Competitive Scenario
- 7.6.2.3. Regulatory Framework
- 7.6.2.4. South Africa Bioprocess Technology Market, 2021 - 2033 (USD Billion)
- 7.6.3. Saudi Arabia
- 7.6.3.1. Key Country Dynamics
- 7.6.3.2. Competitive Scenario
- 7.6.3.3. Regulatory Framework
- 7.6.3.4. Saudi Arabia Bioprocess Technology Market, 2021 - 2033 (USD Billion)
- 7.6.4. UAE
- 7.6.4.1. Key Country Dynamics
- 7.6.4.2. Competitive Scenario
- 7.6.4.3. Regulatory Framework
- 7.6.4.4. UAE Bioprocess Technology Market, 2021 - 2033 (USD Billion)
- 7.6.5. Kuwait
- 7.6.5.1. Key Country Dynamics
- 7.6.5.2. Competitive Scenario
- 7.6.5.3. Regulatory Framework
- 7.6.5.4. Kuwait Bioprocess Technology Market, 2021 - 2033 (USD Billion)
Chapter 8. Competitive Landscape
- 8.1. Company Categorization
- 8.2. Company Market Share/ Position Analysis, 2025
- 8.3. Strategy Mapping
- 8.4. Company Profiles/Listing
- 8.4.1. Thermo Fisher Scientific Inc.
- 8.4.1.1. Overview
- 8.4.1.2. Financial Performance
- 8.4.1.3. Product Benchmarking
- 8.4.1.4. Strategic Initiatives
- 8.4.2. Sartorius AG
- 8.4.2.1. Overview
- 8.4.2.2. Financial Performance
- 8.4.2.3. Product Benchmarking
- 8.4.2.4. Strategic Initiatives
- 8.4.3. Merck KGaA
- 8.4.3.1. Overview
- 8.4.3.2. Financial Performance
- 8.4.3.3. Product Benchmarking
- 8.4.3.4. Strategic Initiatives
- 8.4.4. Danaher Corporation
- 8.4.4.1. Overview
- 8.4.4.2. Financial Performance
- 8.4.4.3. Product Benchmarking
- 8.4.4.4. Strategic Initiatives
- 8.4.5. Corning Incorporated
- 8.4.5.1. Overview
- 8.4.5.2. Financial Performance
- 8.4.5.3. Product Benchmarking
- 8.4.5.4. Strategic Initiatives
- 8.4.6. Eppendorf SE
- 8.4.6.1. Overview
- 8.4.6.2. Financial Performance
- 8.4.6.3. Product Benchmarking
- 8.4.6.4. Strategic Initiatives
- 8.4.7. Getinge AB
- 8.4.7.1. Overview
- 8.4.7.2. Financial Performance
- 8.4.7.3. Product Benchmarking
- 8.4.7.4. Strategic Initiatives
- 8.4.8. Repligen Corporation
- 8.4.8.1. Overview
- 8.4.8.2. Financial Performance
- 8.4.8.3. Product Benchmarking
- 8.4.8.4. Strategic Initiatives
- 8.4.9. ABEC, Inc.
- 8.4.9.1. Overview
- 8.4.9.2. Financial Performance
- 8.4.9.3. Product Benchmarking
- 8.4.9.4. Strategic Initiatives
- 8.4.10. PBS Biotech, Inc.
- 8.4.10.1. Overview
- 8.4.10.2. Financial Performance
- 8.4.10.3. Product Benchmarking
- 8.4.10.4. Strategic Initiatives